China REgistry of WATCHMAN

NCT03014557 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 413

Last updated 2017-01-09

No results posted yet for this study

Summary

This registry is designed to observe the safety and effectiveness of WATCHMAN left atrial appendage closure technology in a Chinese population.

Conditions

Interventions

DEVICE

left atrial appendage closure device implantation

to permanently implant a WATCHMAN left atrial appendage closure device through trans-catheter approach

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY
  • Fu Wai Hospital, Beijing, China

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03014557 on ClinicalTrials.gov